Evidence map›Paper›PMID 17332449›Full record

ArticleStroke2007

IL1RN VNTR polymorphism in ischemic stroke: analysis in 3 populations.

Bradford B Worrall, Thomas G Brott, Robert D Brown, W Mark Brown, Stephen S Rich, Sampath Arepalli, Fabienne Wavrant-De Vrièze, Jaime Duckworth, Andrew B Singleton, John Hardy and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in Stroke, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 2 pooled it
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 2 syntheses or guidelines pooled it, 33 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Bradford B WorrallDepartment of Neurology, University of Virginia Health System, Charlottesville, VA, USA.
Thomas G Brott
Robert D Brown
W Mark Brown
Stephen S Rich
Sampath Arepalli
Fabienne Wavrant-De Vrièze
Jaime Duckworth
Andrew B Singleton
John Hardy
James F Meschia
SWISS, ISGS, and MSGD Investigators
Wake Forest University · USUniversity of Virginia Health System · US

Funding

Siblings With Ischemic Stroke Study (SWISS)R01NS039987 · NINDS · MAYO CLINIC JACKSONVILLE · PI MESCHIA, JAMES F · 2000 to 2009
$9.2M
ISGS: The Ischemic Stroke Genetics StudyR01NS042733 · NINDS · MAYO CLINIC JACKSONVILLE · PI MESCHIA, JAMES F · 2002 to 2006
$3.7M
Cerebrovascular Atherosclerosis: Genes &Gene ExpressionK08NS045802 · NINDS · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI WORRALL, BRADFORD B · 2005 to 2009
$841k
Medical Research Council G0701075NIDDK NIH HHS P50DK0636091NINDS NIH HHS K08 NS045802NINDS NIH HHS K08-NS45802NINDS NIH HHS R01 NS039987NINDS NIH HHS R01 NS042733NINDS NIH HHS R01 NS39987NINDS NIH HHS R01 NS42733
6 · The paper itself

Abstract

background and purposeGenetic factors influence risk for ischemic stroke and likely do so at multiple steps in the pathogenic process. Variants in genes related to inflammation contribute to risk of stroke. The purpose of this study was to confirm our earlier finding of an association between allele 2 of a variable number tandem repeat of the IL-1 receptor antagonist gene (IL1RN) and cerebrovascular disease.

methodsAn association study of the variable number tandem repeat genotype with ischemic stroke and stroke subtypes was performed on samples from a North American study of affected sibling pairs concordant for ischemic stroke and 2 North American cohorts of prospectively ascertained ischemic stroke cases and unrelated controls. DNA analysis was performed on cases and controls, stratified by race.

resultsAfter adjustment for age, sex, and stroke risk factors, the odds ratio for association of allele 2 and ischemic stroke was 2.80 (95% confidence interval, 1.29 to 6.11; P=0.03) for the white participants. The effect of allele 2 of IL1RN on stroke risk most closely fits a recessive genetic model (P=0.009). For the smaller sample of nonwhite participants, the results were not significant.

conclusionsAllele 2 of IL1RN, present in nearly one-quarter of stroke patients, may contribute to genetic risk for ischemic stroke and confirm the previously identified association with cerebrovascular disease. These results are driven by the association in the white participants. Further exploration in a larger nonwhite sample is warranted.

Indexed as

AgedBrain IschemiaCohort StudiesDNA Mutational AnalysisFemaleGene FrequencyGenetic Predisposition to DiseaseGenetic TestingHumansInflammationInterleukin 1 Receptor Antagonist ProteinMaleMiddle AgedMinisatellite RepeatsNorth AmericaPolymorphism, GeneticIL1RN protein, humanInterleukin 1 Receptor Antagonist Protein

Identifiers

PMID17332449
PMCPMC2629799
OpenAlexW1987886182

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.